» Articles » PMID: 36593237

Association of LncRNA-PAX8-AS1 and LAIR-2 Polymorphisms Along with Their Expression with Clinical and Subclinical Hypothyroidism

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jan 2
PMID 36593237
Authors
Affiliations
Soon will be listed here.
Abstract

The genetic and epigenetic architecture of clinical and subclinical hypothyroidism remains unclear. We investigated the impact of long noncoding RNA (LncRNA)-PAX8-AS1 and LAIR-2 genetic variants on the susceptibility to clinical and subclinical hypothyroidism, their influence on LncRNA-PAX8-AS1 and LAIR-2 expression and their potential as hypothyroid biomarkers. Hundred clinical hypothyroid patients, 110 subclinical hypothyroid patients, and 95 healthy controls were enrolled. Gene expression analysis and genotyping were performed by qPCR. LAIR-2 protein, a proinflammatory mediator, was tested by ELISA. Serum LncRNA-PAX8-AS1 was downregulated, whereas LAIR-2 mRNA and protein levels were upregulated in clinical and subclinical hypothyroid patients compared to healthy controls. LncRNA-PAX8-AS1 rs4848320 and rs1110839 were associated with increased risk of clinical hypothyroidism. Interestingly, both SNPs were associated with differential expression of serum LncRNA-PAX8-AS1 among clinical hypothyroid patients. LAIR-2 rs2287828 was associated with elevated risk of both clinical and subclinical hypothyroidism. Harboring the rs2287828 T allele augmented the LAIR-2 mRNA expression among clinical hypothyroid patients, while elevated both LAIR-2 mRNA and protein levels in subclinical hypothyroid patients. The rs4848320-rs1110839-rs2287828 TTT, CTT, and CGT haplotypes were associated with increased hypothyroid risk. Surprisingly, serum LncRNA-PAX8-AS1 and LAIR-2 mRNA expression demonstrated superior diagnostic accuracy for clinical hypothyroidism and turned out as independent predictors in the multivariate analysis. Conclusively, LncRNA-PAX8-AS1 and LAIR-2 genetic variants are novel genetic biomarkers of hypothyroidism that could alter the LncRNA-PAX8-AS1 and LAIR-2 expression. LncRNA-PAX8-AS1 and LAIR-2 expression profiles have the potential as effective diagnostic and prognostic indicators of hypothyroidism.

Citing Articles

The Impact of BMI on PCOS Patients and Transcriptome Profiling and Bioinformatic Analysis of Granulosa Cells in PCOS Patients with High and Low BMI.

Tao P, Yan X, Li Y, Wang Z Reprod Sci. 2025; .

PMID: 39821799 DOI: 10.1007/s43032-024-01783-6.


Serum lncRNAs TUG1, H19, and NEAT1 and their target miR-29b/SLC3A1 axis as possible biomarkers of preeclampsia: Potential clinical insights.

Senousy M, Shaker O, Elmaasrawy A, Ashour A, Alsufyani S, Arab H Noncoding RNA Res. 2024; 9(4):995-1008.

PMID: 39026605 PMC: 11254728. DOI: 10.1016/j.ncrna.2024.06.007.


Association of lncRNA MEG3 rs941576 polymorphism, expression profile, and its related targets with the risk of obesity-related colorectal cancer: potential clinical insights.

Senousy M, Shaker O, Ayeldeen G, Radwan A Sci Rep. 2024; 14(1):10271.

PMID: 38704452 PMC: 11069513. DOI: 10.1038/s41598-024-60265-6.

References
1.
Motawi T, Shaker O, Hassanin S, Ibrahim S, Senousy M . Genetic and epigenetic control on clock genes in multiple sclerosis. J Genet Genomics. 2021; 49(1):74-76. DOI: 10.1016/j.jgg.2021.07.016. View

2.
Taylor P, Porcu E, Chew S, Campbell P, Traglia M, Brown S . Whole-genome sequence-based analysis of thyroid function. Nat Commun. 2015; 6:5681. PMC: 4366514. DOI: 10.1038/ncomms6681. View

3.
Effraimidis G, Watt T, Feldt-Rasmussen U . Levothyroxine Therapy in Elderly Patients With Hypothyroidism. Front Endocrinol (Lausanne). 2021; 12:641560. PMC: 8006441. DOI: 10.3389/fendo.2021.641560. View

4.
Veyrieras J, Kudaravalli S, Kim S, Dermitzakis E, Gilad Y, Stephens M . High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008; 4(10):e1000214. PMC: 2556086. DOI: 10.1371/journal.pgen.1000214. View

5.
Vanderpump M, Tunbridge W . Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 2002; 12(10):839-47. DOI: 10.1089/105072502761016458. View